Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

NCT01841723 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

NIH

Sponsor class

Conditions

Hairy Cell Leukemia
Hairy Cell Leukemia Variant
Recurrent Hairy Cell Leukemia
Recurrent Hairy Cell Leukemia Variant

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Ibrutinib
PROCEDURE: Ultrasound Imaging

Sponsor

National Cancer Institute (NCI)